Head and neck squamous cell carcinomas (HNscc) produce low-molecular-mass factors (low-Mr factors, Mr --<25,000), which are antigenically related to the immunosuppressive retroviral transmembrane envelope protein pl5E. These P15E-related tumour factors are thought to be responsible for some immunological impairments found in these patients (particularly the defective monocyte chemotaxis). A sequential and functional homology has been reported to exist between a bioactive fragment of interferon o~ (IFNo0 and the putative immunosuppressive region of retroviral pl5E . In this study we investigated (a) a possible functional and structural relationship between pl5E and IFNc~, and (b) the presence of and the relationship between pl5E-related lowMr factors and IFNo~ in HNscc patients. We report the following results. (a) Recombinant human (rhu) IFNc~ was able to inhibit monocyte chemotaxis. (b) The anti-pl5E antibodies crossreacted with rhulFN~ in a dot-blot technique; however, the anti-IFNc~ antibodies did not crossreact with disrupted murine leukaemia virus (pl5E source). (c) Low-Mr factors (n = 8-11) prepared from the sera of HNscc patients, which inhibit the monocyte chemotactic responsiveness, could be adsorbed by the anti-pl5E antibodies as well as by the anti-IFNo~ antibodies. However, the abilities of the factors to adsorb to the two categories of antibodies (namely, anti-pl5E and anti-IFNcQ did not correlate. (d) Immunohistochemically we found IFNc~-related epitopes, in almost all HNscc specimens studied (17/18), in locations distinctive from those of pl5E-related factors. The anti-IFNc~ antibodies used in this study mainly reacted with basal epithelial cells close to the basal membrane, the prickle and granular cells of the squamous cell carcinomas. The anti-pl5E antibodies mainly reacted with corneal layers, the granular and prickle cells, and did not react with 
Introduction
Head and neck squamous cell carcinoma (HNscc) patients show several defects ill cell-mediated immunity [1] , most notably in chemotactic responsiveness of blood monocytes [2] . Removal of the HNscc restores this defective chemotactic responsiveness [3] , indicating that the tumor produces immunosuppressive factors. Indeed, low-molecularmass factors (low-Mr factors, Mr --<25,000), which inhibit monocyte and macrophage responses to chemotaxins, have been detected in tumor specimens [4, 5] and sera [6] [7] [8] of HNscc patients. Interestingly, the effect of these factors has been shown to be abrogated with monoclonal antibodies (mAb) directed against a retroviral immunosuppressive protein, pl5E. This was taken as evidence that these low-Mr factors were structurally related to pl5E, and possibly involved in hampering the defense immune response towards cancer cells.
P15E is the transmembrane envelope protein of several animal leukaemogenic retroviruses, such as murine leukaemia virus (MuLV) and feline leukaemia virus (FeLV), and is well known for its immunosuppressive actions (reviewed in [9, 10] ). A synthetic 17-amino-acid peptide (CKS-17), homologous to a highly conserved region in several retroviral transmembrane envelope proteins [11] , has similar immunosuppressive actions, amongst which are inhibition of monocyte chemotactic responsiveness [12] , interleukin-l(IL-1)-mediated monocyte tumour killing [13] , the respiratory burst of human monocytes [14] , the mitogen-and alloantigen-stimulated proliferation of human lymphocytes [15, 16] , immunoglobulin synthesis by B lymphocytes [17] , interferon 7 (IFN7) production [18] , human natural killer (NK) cell activity [19] , and in vivo delayed-type hypersensitivity (DTH) to sheep red blood cells in mice [20] .
Recently, Ruegg et al. [21] identified a CKS-17-1ike conserved region in human interferon c~ (IFNc~), a small fragment which, when presented as a synthetic peptide, inhibited proliferation of both the Daudi lymphoblastoid cell line and anti-CD3-stimulated human T lymphocytes. This fragment exhibited a high degree of amino acid sequential identity (70%) to CKS-17. Recombinant human (rhu) IFNc~ (subtype 2) has a similar antiproliferative action. Wegemer et al. [22] have found a peptide (P+: ISP) comprised of CKS-17 linked to another pl5E-derived sequence (rich in polar positive residues) from FeLV, which like IFNc~ showed antiviral activity on feline-and murinevirus-infected cell lines. These authors postulated that some of the biological effects of P+ : ISP are mediated through a common pathway shared with IFNot.
Since an immunosuppressive CKS-17-1ike sequence is also present in IFNcz, we tried to establish a homologous (chemotactic inhibitory) action between pl5E and IFN(z (Mr = 19,000-26,000 [23] ). To verify this possible homologous action, we investigated the effect of rhuIFNcz on the chemotactic responsiveness of healthy donor monocytes (measured with the monocyte polarization assay, which represents an early event of the chemotactic responsiveness [3, 24] ). We also established the reactivity of the anti-pl5E/ CKS-17 antibodies against rhuIFN(z using a dot-blot technique, and vice versa (anti-IFN(z antibodies to retroviral pl5E). Furthermore, we were interested in whether the pl5E-related HNscc low-Mr factors showed IFN(z relatedness. We therefore analysed the immunoreactivity of antiIFNcz antibodies on tumour specimens and sera of HNscc patients, and compared these data with the immunoreactivity of the anti-pl5E/CKS-17 antibodies. ImmunohistochemistlT. Sections of 4 ~tm thickness were cut using a cryostat, mounted on glass slides, air-dried and acetone-fixed for 10 rain. These sections were pre-incubated with tenfold-diluted normal sera (Dakopatts, Copenhagen, Denmark) depending on the primary antibody step used; normal rabbit serum (using mAb) and normal swine serum (using pAb). The sections were subsequently incubated for 60 rain with the different specific antibodies mentioned above (and controls), washed three times with phosphate-buffered saline (PBS, pH 7.4), and incubated for 30 rain with peroxidase-conjugated immunoglobulins. Subsequently the sections were stained[ using chromagen 1,2-diaminobenzidine (Sigma Chemical Corp., st. Louis, USA), and weakly counterstained with haematoxylin. All the steps described were performed at 21 ~ C, and antibody dilutions were made in PBS/I% bovine serum albumin (Sigma Chemical Co., St. Louis, USA). Antibody protein concentrations were used as shown in Table 1 .
Materials and methods
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Patients. We studied 18 male and 7 female patients, aged 37-72 years, with HNscc of the oral cavity, larynx and oro-and hypopharynx; stages T1N2-T4N2. All patients were treated by surgery and/or radiotherapy at the department of ear, nose and throat/head and neck surgery of the Dijkzigt University Hospital, Rotterdam, the Netherlands. After surgery, neoplastic tissues were snap-frozen in liquid nitrogen and stored at -70 ~ C. Serum samples were obtained by venapuncture and stored at -20 ~ C until use.
Monoclonal and polyclonal antibodies. Anti-(MuLV)pl5E mAb used were 19F8 [25, 26] (IgG2b) and 4F5 [26, 27] (IgG2a). Anti-CKS-17 mAb, directed against CKS-17-cysteine coupled to keyhole limpet haemocyanin (KLH), have been developed at our department (Dr. M. S. Lang, manuscript in preparation). Two anti-CKS-17 mAb were used, ER-IS5 (IgG2b) and ER-IS1 (IgM; called CK1 in [26] ).
Anti-rhuIFN(z2b mAb (IgG1) and polyclonal antibodies (pAb) (IgGs) were a generous gift from Dr. R van der Meyde, TNO Health Research, Rijswijk, the Netherlands.
Control antibodies used were: IgG2a and IgG1 (isotype controls: Becton Dickinson), IgG2b (ICN 64-337 (myeloma source), ICN Biomedical Inc., Costa Mesa, Calif., USA), IgM (blood group antigen A, Dakopatts, Copenhagen, Denmark) and IgGs (rabbit anti-ox red blood cells, Seralab Ltd., Crawley Down, GB).
Isolation of peripheral blood monocytes.
Monocytes ]From healthy donors were isolated via counterflow elutriation centrifugation [7, 12] . These almost pure monocyte fractions were used to test the effects of low-Mr factors in sera of HNscc patients and rhuIFNc~2b on the polarization assay (see below). In brief, mononuclear cells were separated from 450 ml whole blood of healthy individuals via Percoll centrifugation (20 rain, 1000 g). Thereafter, the mononuclear cells were injected into an elutriation centrifugation systetn (Beckman J21 centrifuge with a JE-6 elutriation rotor). The elutriation medium was PBS with 13 mM trisodium citrate and 0.5% human albumin. To separate the different cell populations, the flow rate wag kept constant at 20 ml/min, while the rotor speed decreased from 4000 to 0 rpm. The fraction collected at 2500 rpm contained 93%-97% non-specific-esterase-positive cells [28] . This fraction was used in further experiments after storage in liquid nitrogen as described previously [12] .
The monocyte polarization assay. The Cianciolo and Snyderman [24] assay for monocyte polarization was performed with slight modifications [3] . The outcomes of the assay correlate well with the outcomes of the conventional Boyden chamber assay to measure chemotaxis to formylmethionylleucylphenylalanine (fMetLeuPhe) and casein [3, 24] . Aliquots (0.2 ml) of elutriator-purified cell suspension, containing 0.2x 106 monocytes thawed and washed in RMPI-1640 medium sup-plemented with 10% fetal calf serum (Gibco, Breda, the Netherlands), 2 mM glutamine and antibiotics, were added to 12x75-mm polypropyleue tubes (Falcon Labware Division of Becton Dickinson Corp., Oxford, Calif., USA) containing 0.05 ml medium or fMetLeuPhe (final concentration of 10 nM), or with fMetLeuPhe in combination with HNscc low-Mr factors, before and after adsorption with the different antibodies (see below), or rhuIFNc~2b. The tubes were incubated at 37 ~ C in a waterbath for 15 rain. The incubation was then stopped by addition of 0.25 ml ice-cold 10% formaldehyde in 0.05 M PBS (pH 7.4). The cell suspensions were kept at 4 ~ C until counting in a haemocytometer using an ordinary light microscope (magnification 250x). The test was read "blindly" by two persons; 200 cells were counted from each tube. A cell was "polarized" if any of the following features occurred: (a) elongated or triangular shape; (b) broadened lamellipodia; (c) membrane ruffling.
The percentage of polarized monocytes was calculated as follows:
total cells polarized (%) x 100 ceils positive for non-specific esterase (%) Lymphocytes do not exhibit any polarization activity towards fMetLeuPhe [3] . Depending on the donor, 25%-40% of the monocytes polarized in response to fMetLeuPhe (spontaneous polarization 4%-9%).
The effect of low-molecular-mass factors in sera from patients with head and neck squamous cell carcinoma and recombinant human IFN(x2b on the monocyte polarization assay. Sera were collected as mentioned above and diluted 1 : 1 in PBS. These dilutions were subjected to ultrafiltration through Amicon CF25 Centriflo cones (Amicon Corp., Danvers, USA) for 15 rain at 700 g (Mr "cut-off point" 25,000). The filtrates, low-Mr factors, were dissolved in PBS and stored at -20 ~ C.
The capability of low-Mr factors or rhuIFNc~2b (Intron A; Schering Corp., Kenilworth, N.J., USA) to influence the fMetLeuPhe-induced polarization of healthy donor monocytes was determined by incubating the monocytes (lxl06/ml) for 15 rain at 37 ~ C, either with fMetLeuPhe alone, or with the tripeptide in combination with low-Mr factors (final dilution 1 : 60) or different concentrations of rhulFNe~2b (final concentrations 5 pM-500 nM). The percentage inhibition was calculated as follows:
P1-Po
where P0 = spontaneous polarization (%), P1 = polarization after incubation with fMetLeuPhe (%) and P2 = polarization after incubation with fMetLeuPhe and low-Mr factors or rhuIFN~. Low-Mr factors and rhuIFNc~2b were tested in triplicate, the addition of either of these to donor monocytes unstimulated by fMetLeuPhe did not affect the spontaneous polarization.
Adsorption experiments. To validate the p 15E-like character of low-Mr factors, adsorption experiments were performed by neutralizing the factors before testing their effects on the monocyte polarization assay, with anti-pl5E antibodies, at 4 ~ C for 16 h and then carrying out Amicon ultrafiltration (see above) to remove the antibody-antigen complexes formed. The same procedures were performed for investigating the expression of the CKS-17 domain with an anti-CKS-17 antibody (ER-IS5) and expression of IFNc~2b determinants with antiIFNc~2b antibodies. As control antibodies we used irrelevant mAb and a pAb. Antibody protein concentrations were used as shown in Table 1 .
Dot-blot technique.
Rauscher MuLV (~ 1.0 mg proteirdml), purified as described elsewhere [29] from the JLS-V5 cell line, and rhuIFNc~2b (~0.1 mg rhuIFNc~2b/ml) were applied as dots directly onto nitrocellulose strips (Bio-Rad Lab., Richmond, Calif., USA) in 5-gl volumes, and dried at 70 ~ C for 1 h. The remaining protein-binding sites were blocked with PBS/0.05% gelatin (Gibco Europe Ltd., Paisley, Scotland) for at least i h. The nitrocellulose strips were then incubated overnight with anti-pl5E, anti-CKS-17 and anti-IFNa2b antibodies. Bound antibodies were detected with specific conjugates, SaR-PO and RaM-PO, during a 2-h incubation step. All incubations were performed at 21 ~ C with slow agitation, and between these steps the strips were washed three times with PBS/0.05% Tween 20 (Merck, Mtinchen, Germany). The strips were developed by 0.01% H~O2 and 1.7 mM 4-chloro-l-naphthol (J. T. Barker B. V., Deventer, The Netherlands) in 50 mM TRIS/HC1 buffer (pH 7.2), 7% polyethyleneglycol 6000 (Sigma Chemical Co., St. Louis, USA), for 5-10 rain. Antibody protein concentrations were used as shown in Table 1 .
Results
Effect of recombinant human 1FNo~2b on the monocyte polarization
Since IFNc~ has sequential similarities to retroviral p15E (see Introduction), we were interested in whether it was capable of inhibiting the polarization of healthy monocytes. As shown in Fig. 1, rhuIFNc~2b strongly inhibited the polarization of healthy monocytes in a dose-dependent manner, with a concentration of half-maximum inhibition (ICs0) of about 100 nM (maximum inhibition 100 %; P2 = P0, see Materials and methods). This inhibitory activity of rhuIFNc~2b could not be ascribed to peptide-mediated toxicity: even with the highest concentration tested (5), and anti-IFNo~ mAb (6) and pAb (7) (500 nM) and incubation periods of up to 1 h, none of the monocytes showed altered morphology and an increased trypan blue uptake (data not shown).
Dot-blot technique
To study a possible structural homology between retroviral p l 5 E and human IFNcz, we also investigated whether the specific antibodies reacted with immobilized rhuIFNo~2b
and/or detergent-disrupted MuLV as a source of pl5E, in comparison wih isotype and matched control antibodies. Figure 2 shows that anti-IFN~ antibodies reacted with rhuIFN(~2b, but did not show any reactivity with (dot) blotted disrupted MuLV, indicating that these antibodies showed specificity for rhuIFN~. The anti-pl5E antibodies (19F8 and 4F5) reacted with both rhuIFNc~2b and disrupted MuLV, indicating that these antibodies were not only specific for retroviral p l 5 E but also crossreacted at least to a certain extent with IFNo~. The anti-CKS-17 antibodies (ER-IS5 and ER-IS 1) showed differential patterns of reactivity. Whereas ER-IS 1 clearly reacted with both rhulFNc~2b and MuLV, ER-IS5 only very weakly reacted to disrupted MuLV. Interestingly, the anti-pl5E and anti-IFNc~-specific antibodies were also able to adsorb the rhuIFN~ (500 nM) inhibitory effect on the monocyte polarization (data not shown), confirming the reactivity of all these antibodies with rhulFNcz shown in the dot-blot experiments.
Reactivity of anti-pl 5E, anti-CKS-I7 and anti-IFNo~ antibodies with immunosuppressive low-molecular-mass factors from the sera of patients with head and neck squamous cell carcinoma
Low-Mr factors prepared from the sera of patients with HNscc inhibit the polarization of normal monocytes [ 6 -8] . Table 2 shows the results of adsorption experiments on the low-Mr factors prepared for serum preparations (n = 8 -1 1 ) with the antibodies used in this study (see Table 1 ). The monocyte chemotaxis-inhibitory effect of all low-Mr factors tested could be adsorbed -as has been (eported before -by the anti-pl5E antibodies 19F8 (3 out of 3 HNscc sera tested) and 4F5 (3 out of 3) just as well as by a mixture of these two mAb (8 out of 8). Table 2 . The percentages inhibition by low-Mr factors prepared from sera of patients with head and neck squamous cell carcinoma on the fMetLeuPhe-induced monocyte polarization, before and after adsorption with antibodies directed against retroviral MuLV-pl5E, its putative immunosuppressive (synthetic) CKS-17-region and rhuIFNc~; the difference in inhibition of the polarization after adsorption between specific antibodies and their matching isotype controls was evaluated using the Wilcoxon's rank-sum test A  48  13  24  19  23  55  12  48  25  36  B  40  16  27  31  15  42  15  40  4  41  C  41  25  22  34  16  47  15  41  19  41  D  67  32  ND  ND  42  48  11  48  49  58  E  47  33  ND  ND  28  44  30  50  28  66  F  61  20  ND  ND  51  60  42  57  49  48  G  54  38  ND  ND  29  64  62  39  29  59  H  51  30  ND  ND  48  64  26  54  27  54   I   45  ND  ND  ND  ND  ND  34  ND  ND  ND  J  43  ND  ND  ND  ND  ND  20  ND  ND  ND  K  39  ND  ND  ND  ND  ND  19  ND  ND  ND   Mean  49  26  24  28  32  53  26  47  29  50  SD  9  9  14  9  15  7  15 Interestingly, anti-IFN~2b mAb and pAb were also capable of adsorbing the inhibitory effect of the low-Mr factors. Since the anti-IFNo~ antibodies are specific to IFNo~ (dot-blot technique) and do not react with MuLV-pl5E, the data of Table 2 must be taken as evidence that the majority of the low-Mr factors do contain IFNc~-like molecules as immunosuppressive factors.
However, we could not find a correlation between the adsorption capabilities of the anti-IFNo~ antibodies and the anti-p15E antibodies, and it is thus possible that the low-Mr factors contain both pl5E-and IFNc,-related factors. It is also possible that different affinities of the antibodies, together with heterogeneity of the low-Mr factors, explain the non-correlation.
The relatively weak (as shown in the dot-blot experiment) anti-CKS-17 mAb ER-IS5 adsorbed the inhibitory activity of these inhibitory low-Mr factors to a certain extent (6 out of 8), indicating that these low-Mr factors express the CKS-17-1ike domain, as has been demonstrated previously [26] .
Immunohistochemistry of head and neck squamous cell carcinoma specimens with anti-pl5E, anti-CKS-17 and anti-IFNo~ antibodies
In accordance with our previous reports [5, 26] all (n = 18) HNscc tissue specimens studied showed a positive reactivity with both anti-retroviral pl5E antibodies used, namely 19F8 and 4F5. These antibodies recognize different epitopes on retroviral pl5E [27] ; 19F8 is directed to an epitope in the CKS-17 domain [26] . Antibody 4F5 gave the best results in the immunohistochemistry (Fig. 3b) , with practically no background staining. The positivity with the antibodies was mainly detected in corneal layers of welldifferentiated tumours, and in the granular epithelial cells and prickle cells, staining the whole cytoplasm. Basal cells close to the basal membrane were often negative.
Anti-IFNo~ mAb and pAb also gave positive staining results with almost all (17/18) HNscc tumour specimens. However, the location of the reactivity was different from that of the anti-pl5E antibodies, particularly in the case of the anti-IFNc~ pAb (Fig. 3 c) . This latter antibody clearly reacted with malignant cells in the basal epithelial cell layers close to the basal membrane, as well as with the prickle cell layers. Though this antibody was often reactive to some extent to granular cells and the corneal layers, this reactivity was not as strong as the reactivity with the antipl5E antibodies.
The anti-CKS-17 antibodies, ER-IS5 and ER-IS1, gave staining results combining the results of the anti-pl5E and anti-IFNo~ antibodies: in fact, all layers of the tumours were clearly reactive with these antibodies. It must be noted that ER-IS1 gave for stronger immunostaining results (Fig. 3 d) than did ER-IS5, which appeared to be an antibody with low affinity (see dot-blot and adsorption experiments).
Discussion
In the present study we have shown that rhuIFN~b shares functional (monocyte polarization experiments) and structural (dot-blot technique) homology to retroviral pl5E. Furthermore, our data show that low-Mr factors, prepared from the sera of HNscc patients, do not only contain factors related to retroviral pl5E (as was shown extensively in earlier studies), but also factors that show antigenic similarity to IFNa. These factors appear to be separate, since there were discrepancies found in (a) the low-Mr factor adsorption data and (b) the immunohistochemistry staining results with anti-p 15E and anti-IFNc~ antibodies.
IFNc~ (3//1-= 19,000-26,000 [23] ), well known for its antiviral actions [30] , has been reported to have a wide range of immunosuppressive activities. In vivo, IFNo~ has been shown to decrease DTH responses in mice sensitized with sheep red blood cells [31] . In addition, the generation of antibody-producing cells was inhibited by IFNc~ when it was administered prior to sensitization with sheep red blood cells [32] . In vitro, IFNc~ is antiproliferatively active [30] and suppresses T-helper lymphocytes to stimulate antibody production by B lymphocytes [33] . Furthermore, functional suppression of monocytes/macrophages has been described: inhibition of IFNT-induced-I-ILA-DR expression [34] , -tumoricidal activity [35] and -respiratory burst [36] on macrophages, and blocking of IL-l-induced prostaglandin release from monocytes [37] (IL-1 inhibitor) . Moreover, IFNo~ suppresses the in vitro maturation from human monocytes to macrophages (down-regulation of phagocytosis, complement receptors and lysosomal enzymes [381).
In this report we complement these functional studies on 1FNc~ by showing that rhuIFNa2b also inhibits fMetLeuPhe-induced monocyte polarization. Furthermore, using a modified Boyden chamber assay it was found that the classical chemotaxis is suppressed by rhuIFN(z2b (unpublished observation). Interestingly, the inhibitory activities on monocyte polarization of rhuIFNc~2b were adsorbed by the anti-retroviral pl5E antibodies. One of the latter antibodies, 19F8, recognizes an epitope within the immunosuppressive CKS-17 domain [26] . It is of particular interest that the sequence recognized by this mAb, LQNRRGLD (one-letter amino-acid code), is the sequence that is most similar to a homologous sequence within IFNc~ [21, 22] . This sequence has been postulated to be the minimally required sequence for immunosuppressive activity [16] . Previous studies [21, 22] have shown that the putative immunosuppressive site of retroviral pl5E, CKS-17, also has IFNc~-like antiviral and antiproliferative activities. Moreover, our adsorption results suggest that a sequence similar to LQNRRGLD is clearly expressed in the immunosuppressive serum factors from HNscc patients.
With regard to our finding of the IFNo~-relatedness of at least some of the (HNscc sera) low-Mr factors, Sato et al. [39] have earlier found IFN activity in the sera of HNscc patients. This activity was abrogated with acid treatment. In other patient groups characterized by clear immune disorders, such as patients with systemic lupus erythematosus [40] or AIDS [41] , atypical acid-labile IFNc~ has been demonstrated. It must be noted, however, that this acid lability was due to an acid-labile molecule, associated with, but distinct from "normal" (acid-stable) IFNc~ [42, 43] . In humans, it has been shown that there are at least 15 highly related IFNo~ subtypes [23] , each with characteristic chemical and biological activities. For instance, while IFNc~ is generally known to be an activator of NK cell activity [30] , the subtype IFNc~J lacks this ability and may even block the NK-boosting activity of other IFNo~ subtypes [44] (e. g. IFNc~A). Hence, IFN(x subtypes may exist that antagonize the immunostimulating activities of other subtypes and may even be primarily immunosuppressive.
It is tempting to suggest that the immunosuppressive factors found in HNscc are in fact related to these subtypes of IFNc~, and even that pl5E-related factors may be included in the IFNc~ family.
In conclusion, antigenic similarities observed in this study between pl5E, its synthetic CKS-17 domain and human IFNo~, and their known immunosuppressive action on different immunocompetent "target" cells, suggest a relationship between inhibitory HNscc p 15E-related factors and human IFNc~. It is likely that HNscc produce a set of heterogeneous factors that are IFN(~-and/or pl5E-related and exhibit inhibitory effects on monocyte chemotaxis. Isolation, purification and sequencing of HNscc immunosuppressive factors is of the utmost importance to determine whether these ill-defined factors are indeed related to the IFNc~ family, form a separate variety of products of (endogenous) retroviruses or represent crossreacting activities.
